These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8201520)
1. Prediction of disease-free survival after therapy in Wilms' tumor using nuclear morphometric techniques. Partin AW; Yoo JK; Crooks D; Epstein JI; Beckwith JB; Gearhart JP J Pediatr Surg; 1994 Mar; 29(3):456-60. PubMed ID: 8201520 [TBL] [Abstract][Full Text] [Related]
2. Nuclear morphometry and prognosis in favorable histology Wilms' tumor: A prospective reevaluation. Breslow NE; Partin AW; Lee BR; Guthrie KA; Beckwith JB; Green DM J Clin Oncol; 1999 Jul; 17(7):2123-6. PubMed ID: 10561267 [TBL] [Abstract][Full Text] [Related]
3. The use of nuclear morphometry to predict response to therapy in Wilms' tumor. Gearhart JP; Partin AW; Leventhal B; Beckwith JB; Epstein JI Cancer; 1992 Feb; 69(3):804-8. PubMed ID: 1309682 [TBL] [Abstract][Full Text] [Related]
4. Nuclear morphometric analysis of metastasis in Wilms' tumor after multimodal therapy: comparison with primary tumor. Gearhart JP; Willmann JR; Beckwith JB; Epstein J; Partin AW Urology; 1995 Jan; 45(1):119-23. PubMed ID: 7817463 [TBL] [Abstract][Full Text] [Related]
5. Nuclear morphometry as a predictor of response to therapy in Wilms tumor: a preliminary report. Partin AW; Walsh AC; Epstein JI; Leventhal BG; Gearhart JP J Urol; 1990 Oct; 144(4):952-4. PubMed ID: 2169003 [TBL] [Abstract][Full Text] [Related]
6. The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a review. Partin AW; Gearhart JP; Leonard MP; Leventhal BG; Yoo JK; Crooks D; Epstein JI; Beckwith JB Med Pediatr Oncol; 1993; 21(3):222-9. PubMed ID: 8383283 [TBL] [Abstract][Full Text] [Related]
7. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group. Pritchard-Jones K; Kelsey A; Vujanic G; Imeson J; Hutton C; Mitchell C; ; J Clin Oncol; 2003 Sep; 21(17):3269-75. PubMed ID: 12947062 [TBL] [Abstract][Full Text] [Related]
8. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors. Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878 [TBL] [Abstract][Full Text] [Related]
9. The effect of preoperative therapy on the histologic features of Wilms' tumor. An analysis of cases from the Third National Wilms' Tumor Study. Zuppan CW; Beckwith JB; Weeks DA; Luckey DW; Pringle KC Cancer; 1991 Jul; 68(2):385-94. PubMed ID: 1648997 [TBL] [Abstract][Full Text] [Related]
10. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study. Pritchard J; Imeson J; Barnes J; Cotterill S; Gough D; Marsden HB; Morris-Jones P; Pearson D J Clin Oncol; 1995 Jan; 13(1):124-33. PubMed ID: 7799012 [TBL] [Abstract][Full Text] [Related]
11. Improved survival for children with anaplastic Wilms' tumors. Corey SJ; Andersen JW; Vawter GF; Lack EE; Sallan SE Cancer; 1991 Sep; 68(5):970-4. PubMed ID: 1655221 [TBL] [Abstract][Full Text] [Related]
12. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa. Aronson DC; Hadley GP Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor. Salama A; Kamel A J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934 [TBL] [Abstract][Full Text] [Related]
14. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957 [TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor: diagnosis and treatment in the 1990s. Shochat SJ Semin Pediatr Surg; 1993 Feb; 2(1):59-68. PubMed ID: 8062023 [TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan. Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877 [TBL] [Abstract][Full Text] [Related]
17. The relationship between microsubstaging variables, age at diagnosis, and tumor weight of children with stage I/favorable histology Wilms' tumor. A report from the National Wilms' Tumor study. Green DM; Beckwith JB; Weeks DA; Moksness J; Breslow NE; D'Angio GJ Cancer; 1994 Sep; 74(6):1817-20. PubMed ID: 8082084 [TBL] [Abstract][Full Text] [Related]
18. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor. Wang X; Du G; Wu Y; Zhang Y; Guo F; Liu W; Wu R Int J Oncol; 2020 Feb; 56(2):568-580. PubMed ID: 31894270 [TBL] [Abstract][Full Text] [Related]